NJ State Employees Deferred Compensation Plan’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.27M	Hold	48,000	–	–	0.15%	148
2025 Q1	$1.16M	Buy	48,000 +10,000	+26%	+$242K	0.15%	156
2024 Q4	$1.53M	Hold	38,000	–	–	0.19%	122
2024 Q3	$2.41M	Hold	38,000	–	–	0.29%	81
2024 Q2	$2.01M	Buy	38,000 +29,300	+337%	+$1.55M	0.25%	86
2024 Q1	$713K	Buy	+8,700	New	+$713K	0.09%	227